Heart ultrasound at the bedside to predict problems in pulmonary embolism
Studies whether bedside heart ultrasound predicts complications in emergency patients with pulmonary embolism.
Key facts
- Who runs it
- WellSpan Health
- Where
- York, United StatesSee the site
- Trial code
- Registry title
- Point-of-Care Ultrasound in Predicting Adverse Outcomes in Emergency Department Patients With Acute Pulmonary Embolism
- Status
- Recruiting
- People taking part
- 250 people, planned
- Started
- 9 Sept 2021
- Expected to end
- Dec 2026
- Type of study
- Observational
- Treatments tested
- Point-of-care echocardiography
- Record updated
- 3 June 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults in the emergency department with a new blood clot in the lungs (acute pulmonary embolism) seen on a CT scan. They will have a bedside heart ultrasound.
- Age
- 18 years and older
- Sex
- All sexes
- Disease stage
- Acute pulmonary embolism diagnosed in the emergency department and seen on CT imaging
Main reasons for not taking part
- Younger than 18 years
- Not able to give informed consent
- Being in prison
- The current pulmonary embolism was already diagnosed before this emergency department visit
The registry criteria, word for word
Show all 6 criteriaShow less
Who can take part
- Age >= 18 years of age
- ED diagnosis of acute pulmonary embolism with identification on CT imaging
Who cannot take part
- Current PE previously diagnosed prior to index ED visit
- Age <18 years of age
- Inability to provide informed consent
- Incarceration
Where in United States
- Wellspan York HospitalYork, United StatesContact: Brent Becker, MDTaking people
About the trial
What the trial wants to find out
This study is an observational, prospective study examining the role point-of-care echocardiography of predicting short term adverse outcomes in emergency department patients with acute pulmonary embolism.
Read full original descriptionShow less
The primary objective is to assess the diagnostic performance of ultrasound-guided measures of right ventricular dilation (RVD) and strain in predicting clinical outcomes in acute PE.
The secondary objective is to investigate the utility of combining ultrasound-guided measures of RVD and the pulmonary embolism severity index (PESI) score in predicting adverse outcomes in acute PE.
The group in the trial
- Acute Pulmonary Embolism
Subjects in this single cohort will undergo point-of-care echocardiography at the time of presentation and subsequent follow up to assess for short term adverse events or complications.
Treatment: Point-of-care echocardiography
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Point-of-Care Ultrasound in Predicting Adverse Outcomes in Emergency Department Patients With Acute Pulmonary Embolism
- Plain-language title
- Heart ultrasound at the bedside to predict problems in pulmonary embolismGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 15 November 2026.
- Record updated
- 3 June 2026